Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-14

Clinical Trial Update: Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)

View source ↗

Summary

Clinical trial PREADVISE, investigating whether vitamin E and selenium can prevent Alzheimer’s disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)
  • Vitamin E (tocopherol)

Snippet

Sponsor: Frederick Schmitt | Conditions: Alzheimer Disease | Status: COMPLETED